Epidemiology of pediatric sarcoma in Iran
Abstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1660 |
_version_ | 1811169314288435200 |
---|---|
author | Mehdi Azizmohammad Looha Atieh Akbari Mohammad Esmaeil Akbari Elaheh Zarean Narjes Mehrvar Soheila Khodakarim |
author_facet | Mehdi Azizmohammad Looha Atieh Akbari Mohammad Esmaeil Akbari Elaheh Zarean Narjes Mehrvar Soheila Khodakarim |
author_sort | Mehdi Azizmohammad Looha |
collection | DOAJ |
description | Abstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types. Methods and Results Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age‐standardized incidence rates (ASIRs) and five‐year survival rates were calculated. Conclusion The present study is the first comprehensive study of pediatric sarcomas in Iran, in which a lower incidence and survival rate of MBTs and STSs compared with high‐income countries were found. However, the survival rates of these malignancies were higher in high‐income countries compared to Iran. This study showed the need to improve the quantity and quality of the population‐based registry in Iran for acquiring progress in the prevention and control of sarcomas. |
first_indexed | 2024-04-10T16:40:21Z |
format | Article |
id | doaj.art-be25bc4b8a2a45a48faf6090aede14b6 |
institution | Directory Open Access Journal |
issn | 2573-8348 |
language | English |
last_indexed | 2024-04-10T16:40:21Z |
publishDate | 2023-01-01 |
publisher | Wiley |
record_format | Article |
series | Cancer Reports |
spelling | doaj.art-be25bc4b8a2a45a48faf6090aede14b62023-02-08T07:31:29ZengWileyCancer Reports2573-83482023-01-0161n/an/a10.1002/cnr2.1660Epidemiology of pediatric sarcoma in IranMehdi Azizmohammad Looha0Atieh Akbari1Mohammad Esmaeil Akbari2Elaheh Zarean3Narjes Mehrvar4Soheila Khodakarim5Biostatistics, Pediatric Pathology Research Center Research Institute for Children's Health Tehran IranCancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranSurgical Oncology, Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranBiostatistics, Department of Epidemiology and Biostatistics, School of Public Health Tehran University of Medical Sciences Shahrekord IranMAHAK Hematology Oncology Research Center MAHAK‐HORC, MAHAK Hospital Tehran IranBiostatistics, Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranAbstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types. Methods and Results Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age‐standardized incidence rates (ASIRs) and five‐year survival rates were calculated. Conclusion The present study is the first comprehensive study of pediatric sarcomas in Iran, in which a lower incidence and survival rate of MBTs and STSs compared with high‐income countries were found. However, the survival rates of these malignancies were higher in high‐income countries compared to Iran. This study showed the need to improve the quantity and quality of the population‐based registry in Iran for acquiring progress in the prevention and control of sarcomas.https://doi.org/10.1002/cnr2.1660epidemiologyIran national cancer registrymalignant bone tumorosteosarcomapediatric sarcomarhabdomyosarcoma |
spellingShingle | Mehdi Azizmohammad Looha Atieh Akbari Mohammad Esmaeil Akbari Elaheh Zarean Narjes Mehrvar Soheila Khodakarim Epidemiology of pediatric sarcoma in Iran Cancer Reports epidemiology Iran national cancer registry malignant bone tumor osteosarcoma pediatric sarcoma rhabdomyosarcoma |
title | Epidemiology of pediatric sarcoma in Iran |
title_full | Epidemiology of pediatric sarcoma in Iran |
title_fullStr | Epidemiology of pediatric sarcoma in Iran |
title_full_unstemmed | Epidemiology of pediatric sarcoma in Iran |
title_short | Epidemiology of pediatric sarcoma in Iran |
title_sort | epidemiology of pediatric sarcoma in iran |
topic | epidemiology Iran national cancer registry malignant bone tumor osteosarcoma pediatric sarcoma rhabdomyosarcoma |
url | https://doi.org/10.1002/cnr2.1660 |
work_keys_str_mv | AT mehdiazizmohammadlooha epidemiologyofpediatricsarcomainiran AT atiehakbari epidemiologyofpediatricsarcomainiran AT mohammadesmaeilakbari epidemiologyofpediatricsarcomainiran AT elahehzarean epidemiologyofpediatricsarcomainiran AT narjesmehrvar epidemiologyofpediatricsarcomainiran AT soheilakhodakarim epidemiologyofpediatricsarcomainiran |